Researchers Database
FUJITA TOMOE
Affiliation： Department of Pharmacology and Toxicology Position： Professor | |||
Last Updated :2025/04/28
Research achievements
Published Papers
- A 3-Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP-6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week., Yumizaki T, Maeda M, Fujita T, Kakuyama H, Kumagai Y, Clin Pharmacol Drug Dev, 9(3), 353-365, Apr. 2020
- Pharmacokinetics and Safety of Ranirestat in Patients With Hepatic Impairment., Itou M, Fujita T, Inoue K, Uchida N, Takagaki T, Ishii D, Kakuyama H., J Clin Pharmacol., 60(10), 1397-1403, Oct. 2020
- 5-HT2B Receptors-triggered Serotonin Release from Guinea-pig Isolated Colonic Mucosa：a Role of Endogenous Peptide YY, Ken Kojima, Shu-ichi Kojima, Tomoe Fujita, Dokkyo Journal of Medical Sciences, 48(2), 81-86, 25 Jul. 2021
- Effect of In-vivo Administration of Nafamostat on the Onset of Renal Hyperkalemia and Association of Urine Kallikrein in Rat, Teppei Yamada, Hiromichi Kaneko, Chihiro Inose, Sawako Tanaka-Nakadate, Hiroki Hanawa, Shinsuke Hamaguchi, Shigeki Yamaguchi, Tomoe Fujita, Dokkyo Journal of Medical Sciences, 48(1), 33-42, 25 Mar. 2021
- An exploratory study on the development of drug-induced renal hyperpotassemia in general anesthetized rats., Hanawa H, Yamada T, Tanaka-Nakadate S, Yamaguchi S, Hamaguchi S, Fujita T, Dokkyo Medical Journal, 2(2), 148-157, 25 Jun. 2023
- Development of a Young Rat Hyperkalemia Model with Decreased Renal Excretion of Potassium, Takagi Y, Yamada T, Tanaka-Nakadate S, Fujita T, Yoshihara S., Dokkyo Medical Journal, 2(2), 138-147, 25 Jun. 2023
Original paper
- Investigation of 5-HT3 receptor-triggered serotonin release from guinea-pig isolated colonic mucosa: a role of PYY-containing endocrine cell., Kojima Shu-Ichi;Kojima Ken;Fujita Tomoe, European journal of pharmacology, 799, 196-200, 09 Feb. 2017
- Investigation of 5-HT3 receptor-triggered serotonin release from guinea-pig isolated colonic mucosa: a role of PYY-containing endocrine cell., Kojima Shu-Ichi;Kojima Ken;Fujita Tomoe, European journal of pharmacology, 799, 196-200, 09 Feb. 2017
- Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin., Ouchi Motoshi;Oba Kenzo;Kaku Kohei;Suganami Hideki;Yoshida Akihiro;Fukunaka Yasunori;Jutabha Promsuk;Morita Asuka;Otani Naoyuki;Hayashi Keitaro;Fujita Tomoe;Suzuki Tatsuya;Yasutake Masahiro;Anzai Naohiko, Diabetes, obesity & metabolism, 20(4), 1061-1065, 08 Jan. 2018
- Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin., Ouchi Motoshi;Oba Kenzo;Kaku Kohei;Suganami Hideki;Yoshida Akihiro;Fukunaka Yasunori;Jutabha Promsuk;Morita Asuka;Otani Naoyuki;Hayashi Keitaro;Fujita Tomoe;Suzuki Tatsuya;Yasutake Masahiro;Anzai Naohiko, Diabetes, obesity & metabolism, 20(4), 1061-1065, 08 Jan. 2018
- This is in reply to the Letter by Kahathuduwa et al. titled "Unaccounted for regression to the mean renders conclusion of article titled 'Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin' unsubstantiated"., Ouchi Motoshi;Oba Kenzo;Suganami Hideki;Yoshida Akihiro;Fujita Tomoe;Suzuki Tatsuya;Yasutake Masahiro;Kaku Kohei, Diabetes, obesity & metabolism, 20(8), 2041-2042, 05 Jun. 2018
- This is in reply to the Letter by Kahathuduwa et al. titled "Unaccounted for regression to the mean renders conclusion of article titled 'Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin' unsubstantiated"., Ouchi Motoshi;Oba Kenzo;Suganami Hideki;Yoshida Akihiro;Fujita Tomoe;Suzuki Tatsuya;Yasutake Masahiro;Kaku Kohei, Diabetes, obesity & metabolism, 20(8), 2041-2042, 05 Jun. 2018
- Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice., Kamata Mariko;Amano Hideki;Ito Yoshiya;Fujita Tomoe;Otaka Fumisato;Hosono Kanako;Kamata Kouju;Takeuchi Yasuo;Yokomizo Takehiko;Shimizu Takao;Majima Masataka, PloS one, 14(2), e0202842, 28 Feb. 2019
- Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice., Kamata Mariko;Amano Hideki;Ito Yoshiya;Fujita Tomoe;Otaka Fumisato;Hosono Kanako;Kamata Kouju;Takeuchi Yasuo;Yokomizo Takehiko;Shimizu Takao;Majima Masataka, PloS one, 14(2), e0202842, 28 Feb. 2019
- L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness., Kaminuma Osamu;Nishimura Tomoe;Saeki Mayumi;Yamasaki Norimasa;Ogata Sawako;Fujita Tomoe;Endou Hitoshi;Hayashi Keitaro, Allergology international : official journal of the Japanese Society of Allergology, 69(3), 455-458, 10 Jan. 2020
- L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness., Kaminuma Osamu;Nishimura Tomoe;Saeki Mayumi;Yamasaki Norimasa;Ogata Sawako;Fujita Tomoe;Endou Hitoshi;Hayashi Keitaro, Allergology international : official journal of the Japanese Society of Allergology, 69(3), 455-458, 10 Jan. 2020
- Bladder sensation evaluation of a carrageenan-induced chronic prostatitis model using a direct measurement of the bladder mechanosensitive single-unit afferent nerve activity., Aizawa Naoki;Yamanishi Tomonori;Fujita Tomoe, Neurourology and urodynamics, 39(8), 2111-2119, 29 Jul. 2020
- Bladder sensation evaluation of a carrageenan-induced chronic prostatitis model using a direct measurement of the bladder mechanosensitive single-unit afferent nerve activity., Aizawa Naoki;Yamanishi Tomonori;Fujita Tomoe, Neurourology and urodynamics, 39(8), 2111-2119, 29 Jul. 2020
- Efficacy of the combination of KPR-5714, a novel transient receptor potential melastatin 8 (TRPM8) antagonist, and β3-adrenoceptor agonist or anticholinergic agent on bladder dysfunction in rats with bladder overactivity., Aizawa Naoki;Fujimori Yoshikazu;Nakanishi Osamu;Hayashi Takemitsu;Goi Yoshiaki;Kobayashi Jun-Ichi;Fujita Tomoe, European journal of pharmacology, 899, 173995, 03 Mar. 2021
Unclear